Texas

Resilience System


You are here

Mutations

J&J booster slashes Omicron hospitalisations -South African study

Johnson & Johnson's booster shot provides high levels of protection against the omicron variant of Covid-19, according to data from a trial of healthcare workers in South Africa released Thursday.

Preliminary results from the Sisonke study, which have not been peer-reviewed, found that for people who had received one vaccine dose, the booster improved protection against hospitalization to 85 percent from 63 percent.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

More U.S. children are being treated for Covid, but Omicron cases do not seem so severe.

The latest coronavirus surge sweeping the United States, much of it driven by the highly contagious Omicron variant, has produced a worrisome rise in hospitalizations among children, not to mention heightened anxiety among parents nationwide.

Several states have reported increases of about 50 percent in pediatric admissions for Covid-19 in December. New York City has experienced the most dramatic rise, with 68 children hospitalized last week, a fourfold jump from two weeks earlier.

But even as experts expressed concern about a marked jump in hospitalizations — an increase more than double that among adults — doctors and researchers said they were not seeing evidence that Omicron was more threatening to children.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Mutations
howdy folks
Page loaded in 0.829 seconds.